APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bifidobacterium Animalis

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Bifidobacterium Animalis Market Analysis and Forecast 2026-2032

24 December 2025213 pages

Choose your research edition.

Industry ResearchBifidobacterium Animalis Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Bifidobacterium Animalis Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Bifidobacterium Animalis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bifidobacterium Animalis Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Bifidobacterium Animalis Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Bifidobacterium Animalis market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Bifidobacterium Animalis's global sales reached XX (t) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned ADM as the global sales leader, a title it has maintained for several consecutive years. Notably, ADM's performance in primary markets is also remarkable. In the Chinese market, sales were XX (t), a change of XX% from the previous year. In Europe, sales were XX (t), showing a year-on-year of XX%. In the US, sales were XX (t), a year-on-year change of XX%.

The major global manufacturers in the Bifidobacterium Animalis market include ADM, ATCC, Chr. Hansen, Creative Biolabs, DuPont Nutrition & Biosciences, Fengchen Group, Microbiologics, Morinaga and SynBalance, etc. In 2025, the top three vendors accounted for approximately % of the revenue.

Read the full market overview

In terms of production side, this report researches the Bifidobacterium Animalis production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.

In terms of consumption side, this report focuses on the sales of Bifidobacterium Animalis by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.

This report presents an overview of global market for Bifidobacterium Animalis, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Bifidobacterium Animalis, also provides the consumption of main regions and countries. Of the upcoming market potential for Bifidobacterium Animalis, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Bifidobacterium Animalis sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Bifidobacterium Animalis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Bifidobacterium Animalis sales, projected growth trends, production technology, application and end-user industry.

Bifidobacterium Animalis Segment by Company

ADM

ATCC

Chr. Hansen

Creative Biolabs

DuPont Nutrition & Biosciences

Fengchen Group

Microbiologics

Morinaga

SynBalance

BGI Nutri

Wecare Probiotics

Yili Group

Wisbiom (Beijing) Biotechnology

Bifidobacterium Animalis Segment by Type

Bifidobacterium Animalis Subsp. Lactis

Bifidobacterium Animalis Subsp.

Bifidobacterium Animalis Segment by Application

Medicine and Health Products

Food

Clinical Auxiliary Treatment

Animal Feed

Other

Bifidobacterium Animalis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bifidobacterium Animalis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bifidobacterium Animalis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bifidobacterium Animalis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Bifidobacterium Animalis production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of Bifidobacterium Animalis in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of Bifidobacterium Animalis manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bifidobacterium Animalis sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Bifidobacterium Animalis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Bifidobacterium Animalis Subsp. Lactis Major Manufacturers Table 3. Bifidobacterium Animalis Subsp. Major Manufacturers Table 4. Global Bifidobacterium Animalis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Medicine and Health Products Major Manufacturers Table 6. Food Major Manufacturers Table 7. Clinical Auxiliary Treatment Major Manufacturers Table 8. Animal Feed Major Manufacturers Table 9. Other Major Manufacturers Table 10. Bifidobacterium Animalis Industry Trends Table 11. Bifidobacterium Animalis Industry Drivers Table 12. Bifidobacterium Animalis Industry Opportunities and Challenges Table 13. Bifidobacterium Animalis Industry Restraints Table 14. Global Bifidobacterium Animalis Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (t) Table 15. Global Bifidobacterium Animalis Production by Region (2021-2026) & (t) Table 16. Global Bifidobacterium Animalis Production by Region (2027-2032) & (t) Table 17. Global Bifidobacterium Animalis Production Market Share by Region (2021-2026) Table 18. Global Bifidobacterium Animalis Production Market Share by Region (2027-2032) Table 19. Global Bifidobacterium Animalis Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Bifidobacterium Animalis Revenue by Region (2021-2026) & (US$ Million) Table 21. Global Bifidobacterium Animalis Revenue by Region (2027-2032) & (US$ Million) Table 22. Global Bifidobacterium Animalis Revenue Market Share by Region (2021-2026) Table 23. Global Bifidobacterium Animalis Revenue Market Share by Region (2027-2032) Table 24. Global Bifidobacterium Animalis Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (t) Table 25. Global Bifidobacterium Animalis Sales by Region (2021-2026) & (t) Table 26. Global Bifidobacterium Animalis Sales by Region (2027-2032) & (t) Table 27. Global Bifidobacterium Animalis Sales Market Share by Region (2021-2026) Table 28. Global Bifidobacterium Animalis Sales Market Share by Region (2027-2032) Table 29. Global Bifidobacterium Animalis Revenue by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Bifidobacterium Animalis Revenue Market Share by Manufacturers (2021-2026) Table 31. Global Bifidobacterium Animalis Sales by Manufacturers (US$ Million) & (2021-2026) Table 32. Global Bifidobacterium Animalis Sales Market Share by Manufacturers (2021-2026) Table 33. Global Bifidobacterium Animalis Sales Price (USD/t) of Manufacturers (2021-2026) Table 34. Global Bifidobacterium Animalis Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 35. Global Bifidobacterium Animalis Key Manufacturers Manufacturing Sites & Headquarters Table 36. Global Bifidobacterium Animalis Manufacturers, Product Type & Application Table 37. Global Bifidobacterium Animalis Manufacturers Commercialization Time Table 38. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 39. Global Bifidobacterium Animalis by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 40. Global Bifidobacterium Animalis Revenue by Type (2021-2026) & (US$ Million) Table 41. Global Bifidobacterium Animalis Revenue by Type (2027-2032) & (US$ Million) Table 42. Global Bifidobacterium Animalis Revenue Market Share by Type (2021-2026) Table 43. Global Bifidobacterium Animalis Revenue Market Share by Type (2027-2032) Table 44. Global Bifidobacterium Animalis Sales by Type (2021-2026) & (t) Table 45. Global Bifidobacterium Animalis Sales by Type (2027-2032) & (t) Table 46. Global Bifidobacterium Animalis Sales Market Share by Type (2021-2026) Table 47. Global Bifidobacterium Animalis Sales Market Share by Type (2027-2032) Table 48. Global Bifidobacterium Animalis Price by Type (2021-2026) & (USD/t) Table 49. Global Bifidobacterium Animalis Price by Type (2027-2032) & (USD/t) Table 50. Global Bifidobacterium Animalis Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Bifidobacterium Animalis Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Bifidobacterium Animalis Revenue Market Share by Application (2021-2026) Table 53. Global Bifidobacterium Animalis Revenue Market Share by Application (2027-2032) Table 54. Global Bifidobacterium Animalis Sales by Application (2021-2026) & (t) Table 55. Global Bifidobacterium Animalis Sales by Application (2027-2032) & (t) Table 56. Global Bifidobacterium Animalis Sales Market Share by Application (2021-2026) Table 57. Global Bifidobacterium Animalis Sales Market Share by Application (2027-2032) Table 58. Global Bifidobacterium Animalis Price by Application (2021-2026) & (USD/t) Table 59. Global Bifidobacterium Animalis Price by Application (2027-2032) & (USD/t) Table 60. ADM Company Information Table 61. ADM Business Overview Table 62. ADM Bifidobacterium Animalis Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 63. ADM Bifidobacterium Animalis Product Portfolio Table 64. ADM Recent Development Table 65. ATCC Company Information Table 66. ATCC Business Overview Table 67. ATCC Bifidobacterium Animalis Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 68. ATCC Bifidobacterium Animalis Product Portfolio Table 69. ATCC Recent Development Table 70. Chr. Hansen Company Information Table 71. Chr. Hansen Business Overview Table 72. Chr. Hansen Bifidobacterium Animalis Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 73. Chr. Hansen Bifidobacterium Animalis Product Portfolio Table 74. Chr. Hansen Recent Development Table 75. Creative Biolabs Company Information Table 76. Creative Biolabs Business Overview Table 77. Creative Biolabs Bifidobacterium Animalis Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 78. Creative Biolabs Bifidobacterium Animalis Product Portfolio Table 79. Creative Biolabs Recent Development Table 80. DuPont Nutrition & Biosciences Company Information Table 81. DuPont Nutrition & Biosciences Business Overview Table 82. DuPont Nutrition & Biosciences Bifidobacterium Animalis Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 83. DuPont Nutrition & Biosciences Bifidobacterium Animalis Product Portfolio Table 84. DuPont Nutrition & Biosciences Recent Development Table 85. Fengchen Group Company Information Table 86. Fengchen Group Business Overview Table 87. Fengchen Group Bifidobacterium Animalis Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 88. Fengchen Group Bifidobacterium Animalis Product Portfolio Table 89. Fengchen Group Recent Development Table 90. Microbiologics Company Information Table 91. Microbiologics Business Overview Table 92. Microbiologics Bifidobacterium Animalis Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 93. Microbiologics Bifidobacterium Animalis Product Portfolio Table 94. Microbiologics Recent Development Table 95. Morinaga Company Information Table 96. Morinaga Business Overview Table 97. Morinaga Bifidobacterium Animalis Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 98. Morinaga Bifidobacterium Animalis Product Portfolio Table 99. Morinaga Recent Development Table 100. SynBalance Company Information Table 101. SynBalance Business Overview Table 102. SynBalance Bifidobacterium Animalis Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 103. SynBalance Bifidobacterium Animalis Product Portfolio Table 104. SynBalance Recent Development Table 105. BGI Nutri Company Information Table 106. BGI Nutri Business Overview Table 107. BGI Nutri Bifidobacterium Animalis Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 108. BGI Nutri Bifidobacterium Animalis Product Portfolio Table 109. BGI Nutri Recent Development Table 110. Wecare Probiotics Company Information Table 111. Wecare Probiotics Business Overview Table 112. Wecare Probiotics Bifidobacterium Animalis Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 113. Wecare Probiotics Bifidobacterium Animalis Product Portfolio Table 114. Wecare Probiotics Recent Development Table 115. Yili Group Company Information Table 116. Yili Group Business Overview Table 117. Yili Group Bifidobacterium Animalis Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 118. Yili Group Bifidobacterium Animalis Product Portfolio Table 119. Yili Group Recent Development Table 120. Wisbiom (Beijing) Biotechnology Company Information Table 121. Wisbiom (Beijing) Biotechnology Business Overview Table 122. Wisbiom (Beijing) Biotechnology Bifidobacterium Animalis Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 123. Wisbiom (Beijing) Biotechnology Bifidobacterium Animalis Product Portfolio Table 124. Wisbiom (Beijing) Biotechnology Recent Development Table 125. North America Bifidobacterium Animalis Revenue by Type (2021-2026) & (US$ Million) Table 126. North America Bifidobacterium Animalis Revenue by Type (2027-2032) & (US$ Million) Table 127. North America Bifidobacterium Animalis Sales by Type (2021-2026) & (t) Table 128. North America Bifidobacterium Animalis Sales by Type (2027-2032) & (t) Table 129. North America Bifidobacterium Animalis Sales Price by Type (2021-2026) & (USD/t) Table 130. North America Bifidobacterium Animalis Sales Price by Type (2027-2032) & (USD/t) Table 131. North America Bifidobacterium Animalis Revenue by Application (2021-2026) & (US$ Million) Table 132. North America Bifidobacterium Animalis Revenue by Application (2027-2032) & (US$ Million) Table 133. North America Bifidobacterium Animalis Sales by Application (2021-2026) & (t) Table 134. North America Bifidobacterium Animalis Sales by Application (2027-2032) & (t) Table 135. North America Bifidobacterium Animalis Sales Price by Application (2021-2026) & (USD/t) Table 136. North America Bifidobacterium Animalis Sales Price by Application (2027-2032) & (USD/t) Table 137. North America Bifidobacterium Animalis Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. North America Bifidobacterium Animalis Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 139. North America Bifidobacterium Animalis Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 140. North America Bifidobacterium Animalis Sales by Country (2021 VS 2025 VS 2032) & (t) Table 141. North America Bifidobacterium Animalis Sales by Country (2021-2026) & (t) Table 142. North America Bifidobacterium Animalis Sales by Country (2027-2032) & (t) Table 143. North America Bifidobacterium Animalis Sales Price by Country (2021-2026) & (USD/t) Table 144. North America Bifidobacterium Animalis Sales Price by Country (2027-2032) & (USD/t) Table 145. United States Bifidobacterium Animalis Revenue (2021-2032) & (US$ Million) Table 146. Canada Bifidobacterium Animalis Revenue (2021-2032) & (US$ Million) Table 147. Mexico Bifidobacterium Animalis Revenue (2021-2032) & (US$ Million) Table 148. Europe Bifidobacterium Animalis Revenue by Type (2021-2026) & (US$ Million) Table 149. Europe Bifidobacterium Animalis Revenue by Type (2027-2032) & (US$ Million) Table 150. Europe Bifidobacterium Animalis Sales by Type (2021-2026) & (t) Table 151. Europe Bifidobacterium Animalis Sales by Type (2027-2032) & (t) Table 152. Europe Bifidobacterium Animalis Sales Price by Type (2021-2026) & (USD/t) Table 153. Europe Bifidobacterium Animalis Sales Price by Type (2027-2032) & (USD/t) Table 154. Europe Bifidobacterium Animalis Revenue by Application (2021-2026) & (US$ Million) Table 155. Europe Bifidobacterium Animalis Revenue by Application (2027-2032) & (US$ Million) Table 156. Europe Bifidobacterium Animalis Sales by Application (2021-2026) & (t) Table 157. Europe Bifidobacterium Animalis Sales by Application (2027-2032) & (t) Table 158. Europe Bifidobacterium Animalis Sales Price by Application (2021-2026) & (USD/t) Table 159. Europe Bifidobacterium Animalis Sales Price by Application (2027-2032) & (USD/t) Table 160. Europe Bifidobacterium Animalis Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 161. Europe Bifidobacterium Animalis Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 162. Europe Bifidobacterium Animalis Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 163. Europe Bifidobacterium Animalis Sales by Country (2021 VS 2025 VS 2032) & (t) Table 164. Europe Bifidobacterium Animalis Sales by Country (2021-2026) & (t) Table 165. Europe Bifidobacterium Animalis Sales by Country (2027-2032) & (t) Table 166. Europe Bifidobacterium Animalis Sales Price by Country (2021-2026) & (USD/t) Table 167. Europe Bifidobacterium Animalis Sales Price by Country (2027-2032) & (USD/t) Table 168. Germany Bifidobacterium Animalis Revenue (2021-2032) & (US$ Million) Table 169. France Bifidobacterium Animalis Revenue (2021-2032) & (US$ Million) Table 170. U.K. Bifidobacterium Animalis Revenue (2021-2032) & (US$ Million) Table 171. Italy Bifidobacterium Animalis Revenue (2021-2032) & (US$ Million) Table 172. Russia Bifidobacterium Animalis Revenue (2021-2032) & (US$ Million) Table 173. Spain Bifidobacterium Animalis Revenue (2021-2032) & (US$ Million) Table 174. Netherlands Bifidobacterium Animalis Revenue (2021-2032) & (US$ Million) Table 175. Switzerland Bifidobacterium Animalis Revenue (2021-2032) & (US$ Million) Table 176. Sweden Bifidobacterium Animalis Revenue (2021-2032) & (US$ Million) Table 177. Poland Bifidobacterium Animalis Revenue (2021-2032) & (US$ Million) Table 178. China Bifidobacterium Animalis Revenue by Type (2021-2026) & (US$ Million) Table 179. China Bifidobacterium Animalis Revenue by Type (2027-2032) & (US$ Million) Table 180. China Bifidobacterium Animalis Sales by Type (2021-2026) & (t) Table 181. China Bifidobacterium Animalis Sales by Type (2027-2032) & (t) Table 182. China Bifidobacterium Animalis Sales Price by Type (2021-2026) & (USD/t) Table 183. China Bifidobacterium Animalis Sales Price by Type (2027-2032) & (USD/t) Table 184. China Bifidobacterium Animalis Revenue by Application (2021-2026) & (US$ Million) Table 185. China Bifidobacterium Animalis Revenue by Application (2027-2032) & (US$ Million) Table 186. China Bifidobacterium Animalis Sales by Application (2021-2026) & (t) Table 187. China Bifidobacterium Animalis Sales by Application (2027-2032) & (t) Table 188. China Bifidobacterium Animalis Sales Price by Application (2021-2026) & (USD/t) Table 189. China Bifidobacterium Animalis Sales Price by Application (2027-2032) & (USD/t) Table 190. Asia Bifidobacterium Animalis Revenue by Type (2021-2026) & (US$ Million) Table 191. Asia Bifidobacterium Animalis Revenue by Type (2027-2032) & (US$ Million) Table 192. Asia Bifidobacterium Animalis Sales by Type (2021-2026) & (t) Table 193. Asia Bifidobacterium Animalis Sales by Type (2027-2032) & (t) Table 194. Asia Bifidobacterium Animalis Sales Price by Type (2021-2026) & (USD/t) Table 195. Asia Bifidobacterium Animalis Sales Price by Type (2027-2032) & (USD/t) Table 196. Asia Bifidobacterium Animalis Revenue by Application (2021-2026) & (US$ Million) Table 197. Asia Bifidobacterium Animalis Revenue by Application (2027-2032) & (US$ Million) Table 198. Asia Bifidobacterium Animalis Sales by Application (2021-2026) & (t) Table 199. Asia Bifidobacterium Animalis Sales by Application (2027-2032) & (t) Table 200. Asia Bifidobacterium Animalis Sales Price by Application (2021-2026) & (USD/t) Table 201. Asia Bifidobacterium Animalis Sales Price by Application (2027-2032) & (USD/t) Table 202. Asia Bifidobacterium Animalis Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 203. Asia Bifidobacterium Animalis Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 204. Asia Bifidobacterium Animalis Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 205. Asia Bifidobacterium Animalis Sales by Country (2021 VS 2025 VS 2032) & (t) Table 206. Asia Bifidobacterium Animalis Sales by Country (2021-2026) & (t) Table 207. Asia Bifidobacterium Animalis Sales by Country (2027-2032) & (t) Table 208. Asia Bifidobacterium Animalis Sales Price by Country (2021-2026) & (USD/t) Table 209. Asia Bifidobacterium Animalis Sales Price by Country (2027-2032) & (USD/t) Table 210. Japan Bifidobacterium Animalis Revenue (2021-2032) & (US$ Million) Table 211. South Korea Bifidobacterium Animalis Revenue (2021-2032) & (US$ Million) Table 212. India Bifidobacterium Animalis Revenue (2021-2032) & (US$ Million) Table 213. Australia Bifidobacterium Animalis Revenue (2021-2032) & (US$ Million) Table 214. Taiwan Bifidobacterium Animalis Revenue (2021-2032) & (US$ Million) Table 215. Southeast Asia Bifidobacterium Animalis Revenue (2021-2032) & (US$ Million) Table 216. SAMEA Bifidobacterium Animalis Revenue by Type (2021-2026) & (US$ Million) Table 217. SAMEA Bifidobacterium Animalis Revenue by Type (2027-2032) & (US$ Million) Table 218. SAMEA Bifidobacterium Animalis Sales by Type (2021-2026) & (t) Table 219. SAMEA Bifidobacterium Animalis Sales by Type (2027-2032) & (t) Table 220. SAMEA Bifidobacterium Animalis Sales Price by Type (2021-2026) & (USD/t) Table 221. SAMEA Bifidobacterium Animalis Sales Price by Type (2027-2032) & (USD/t) Table 222. SAMEA Bifidobacterium Animalis Revenue by Application (2021-2026) & (US$ Million) Table 223. SAMEA Bifidobacterium Animalis Revenue by Application (2027-2032) & (US$ Million) Table 224. SAMEA Bifidobacterium Animalis Sales by Application (2021-2026) & (t) Table 225. SAMEA Bifidobacterium Animalis Sales by Application (2027-2032) & (t) Table 226. SAMEA Bifidobacterium Animalis Sales Price by Application (2021-2026) & (USD/t) Table 227. SAMEA Bifidobacterium Animalis Sales Price by Application (2027-2032) & (USD/t) Table 228. SAMEA Bifidobacterium Animalis Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 229. SAMEA Bifidobacterium Animalis Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 230. SAMEA Bifidobacterium Animalis Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 231. SAMEA Bifidobacterium Animalis Sales by Country (2021 VS 2025 VS 2032) & (t) Table 232. SAMEA Bifidobacterium Animalis Sales by Country (2021-2026) & (t) Table 233. SAMEA Bifidobacterium Animalis Sales by Country (2027-2032) & (t) Table 234. SAMEA Bifidobacterium Animalis Sales Price by Country (2021-2026) & (USD/t) Table 235. SAMEA Bifidobacterium Animalis Sales Price by Country (2027-2032) & (USD/t) Table 236. Brazil Bifidobacterium Animalis Revenue (2021-2032) & (US$ Million) Table 237. Argentina Bifidobacterium Animalis Revenue (2021-2032) & (US$ Million) Table 238. Chile Bifidobacterium Animalis Revenue (2021-2032) & (US$ Million) Table 239. Colombia Bifidobacterium Animalis Revenue (2021-2032) & (US$ Million) Table 240. Peru Bifidobacterium Animalis Revenue (2021-2032) & (US$ Million) Table 241. Saudi Arabia Bifidobacterium Animalis Revenue (2021-2032) & (US$ Million) Table 242. Israel Bifidobacterium Animalis Revenue (2021-2032) & (US$ Million) Table 243. UAE Bifidobacterium Animalis Revenue (2021-2032) & (US$ Million) Table 244. Turkey Bifidobacterium Animalis Revenue (2021-2032) & (US$ Million) Table 245. Iran Bifidobacterium Animalis Revenue (2021-2032) & (US$ Million) Table 246. Egypt Bifidobacterium Animalis Revenue (2021-2032) & (US$ Million) Table 247. Key Raw Materials Table 248. Raw Materials Key Suppliers Table 249. Bifidobacterium Animalis Distributors List Table 250. Bifidobacterium Animalis Customers List Table 251. Research Programs/Design for This Report Table 252. Authors List of This Report Table 253. Secondary Sources Table 254. Primary Sources List of Figures Figure 1. Bifidobacterium Animalis Product Image Figure 2. Global Bifidobacterium Animalis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bifidobacterium Animalis Market Size Share 2021 VS 2025 VS 2032 Figure . Bifidobacterium Animalis Subsp. Lactis Image Figure 1. Bifidobacterium Animalis Subsp. Image Figure 2. Global Bifidobacterium Animalis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bifidobacterium Animalis Market Size Share 2021 VS 2025 VS 2032 Figure 4. Medicine and Health Products Image Figure 5. Food Image Figure 6. Clinical Auxiliary Treatment Image Figure 7. Animal Feed Image Figure 8. Other Image Figure 9. Global Bifidobacterium Animalis Capacity, Capacity Utilization (2021-2032) & (t) Figure 10. Global Bifidobacterium Animalis Production by Region: 2021 VS 2025 VS 2032 (t) Figure 11. Global Bifidobacterium Animalis Production Market Share by Region: 2025 Versus 2032 Figure 12. Global Bifidobacterium Animalis Production Market Share by Region (2021-2032) Figure 13. North America Bifidobacterium Animalis Production Growth Rate (2021-2032) & (t) Figure 14. Europe Bifidobacterium Animalis Production Growth Rate (2021-2032) & (t) Figure 15. China Bifidobacterium Animalis Production Growth Rate (2021-2032) & (t) Figure 16. Japan Bifidobacterium Animalis Production Growth Rate (2021-2032) & (t) Figure 17. Global Bifidobacterium Animalis Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Bifidobacterium Animalis Revenue (2021-2032) & (US$ Million) Figure 19. Global Bifidobacterium Animalis Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Bifidobacterium Animalis Revenue Market Share by Region: 2025 Versus 2032 Figure 21. Global Bifidobacterium Animalis Revenue Market Share by Region (2021-2032) Figure 22. Global Bifidobacterium Animalis Sales (2021-2032) & (t) Figure 23. Global Bifidobacterium Animalis Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 24. Global Bifidobacterium Animalis Sales Market Share by Region (2021-2032) Figure 25. North America Bifidobacterium Animalis Sales YoY (2021-2032) & (t) Figure 26. Europe Bifidobacterium Animalis Sales YoY (2021-2032) & (t) Figure 27. China Bifidobacterium Animalis Sales YoY (2021-2032) & (t) Figure 28. Asia (Excluding China) Bifidobacterium Animalis Sales YoY (2021-2032) & (t) Figure 29. South America, Middle East and Africa Bifidobacterium Animalis Sales YoY (2021-2032) & (t) Figure 30. Global Bifidobacterium Animalis Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 31. Global Bifidobacterium Animalis Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 32. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Global Bifidobacterium Animalis Revenue Market Share by Type (2021-2032) Figure 34. Global Bifidobacterium Animalis Sales Market Share by Type (2021-2032) Figure 35. Global Bifidobacterium Animalis Revenue Market Share by Application (2021-2032) Figure 36. Global Bifidobacterium Animalis Sales Market Share by Application (2021-2032) Figure 37. North America Bifidobacterium Animalis Revenue Share by Type (2021-2032) Figure 38. North America Bifidobacterium Animalis Sales Share by Type (2021-2032) Figure 39. North America Bifidobacterium Animalis Revenue Share by Application (2021-2032) Figure 40. North America Bifidobacterium Animalis Sales Share by Application (2021-2032) Figure 41. North America Bifidobacterium Animalis Revenue Share by Country (2021-2032) Figure 42. North America Bifidobacterium Animalis Sales Share by Country (2021-2032) Figure 43. Europe Bifidobacterium Animalis Revenue Share by Type (2021-2032) Figure 44. Europe Bifidobacterium Animalis Sales Share by Type (2021-2032) Figure 45. Europe Bifidobacterium Animalis Revenue Share by Application (2021-2032) Figure 46. Europe Bifidobacterium Animalis Sales Share by Application (2021-2032) Figure 47. Europe Bifidobacterium Animalis Revenue Share by Country (2021-2032) Figure 48. Europe Bifidobacterium Animalis Sales Share by Country (2021-2032) Figure 49. China Bifidobacterium Animalis Revenue Share by Type (2021-2032) Figure 50. China Bifidobacterium Animalis Sales Share by Type (2021-2032) Figure 51. China Bifidobacterium Animalis Revenue Share by Application (2021-2032) Figure 52. China Bifidobacterium Animalis Sales Share by Application (2021-2032) Figure 53. Asia Bifidobacterium Animalis Revenue Share by Type (2021-2032) Figure 54. Asia Bifidobacterium Animalis Sales Share by Type (2021-2032) Figure 55. Asia Bifidobacterium Animalis Revenue Share by Application (2021-2032) Figure 56. Asia Bifidobacterium Animalis Sales Share by Application (2021-2032) Figure 57. Asia Bifidobacterium Animalis Revenue Share by Country (2021-2032) Figure 58. Asia Bifidobacterium Animalis Sales Share by Country (2021-2032) Figure 59. SAMEA Bifidobacterium Animalis Revenue Share by Type (2021-2032) Figure 60. SAMEA Bifidobacterium Animalis Sales Share by Type (2021-2032) Figure 61. SAMEA Bifidobacterium Animalis Revenue Share by Application (2021-2032) Figure 62. SAMEA Bifidobacterium Animalis Sales Share by Application (2021-2032) Figure 63. SAMEA Bifidobacterium Animalis Revenue Share by Country (2021-2032) Figure 64. SAMEA Bifidobacterium Animalis Sales Share by Country (2021-2032) Figure 65. Bifidobacterium Animalis Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Bifidobacterium Animalis Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Bifidobacterium Animalis Subsp. Lactis
  • Bifidobacterium Animalis Subsp.
Applications
  • Medicine and Health Products
  • Food
  • Clinical Auxiliary Treatment
  • Animal Feed
  • Other
Companies covered
  • ADM
  • ATCC
  • Chr. Hansen
  • Creative Biolabs
  • DuPont Nutrition & Biosciences
  • Fengchen Group
  • Microbiologics
  • Morinaga
  • SynBalance
  • BGI Nutri
  • Wecare Probiotics
  • Yili Group
  • Wisbiom (Beijing) Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Bifidobacterium Animalis Market by Type
  3. 1.2.1 Global Bifidobacterium Animalis Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Bifidobacterium Animalis Subsp. Lactis
  5. 1.2.3 Bifidobacterium Animalis Subsp.
  6. 1.3 Bifidobacterium Animalis Market by Application
  7. 1.3.1 Global Bifidobacterium Animalis Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Medicine and Health Products
  9. 1.3.3 Food
  10. 1.3.4 Clinical Auxiliary Treatment
  11. 1.3.5 Animal Feed
  12. 1.3.6 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Bifidobacterium Animalis Market Dynamics
  1. 2.1 Bifidobacterium Animalis Industry Trends
  2. 2.2 Bifidobacterium Animalis Industry Drivers
  3. 2.3 Bifidobacterium Animalis Industry Opportunities and Challenges
  4. 2.4 Bifidobacterium Animalis Industry Restraints
3 Global Bifidobacterium Animalis Production Overview
  1. 3.1 Global Bifidobacterium Animalis Production Capacity (2021-2032)
  2. 3.2 Global Bifidobacterium Animalis Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global Bifidobacterium Animalis Production by Region
  4. 3.3.1 Global Bifidobacterium Animalis Production by Region (2021-2026)
  5. 3.3.2 Global Bifidobacterium Animalis Production by Region (2027-2032)
  6. 3.3.3 Global Bifidobacterium Animalis Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
4 Global Market Growth Prospects
  1. 4.1 Global Bifidobacterium Animalis Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global Bifidobacterium Animalis Revenue by Region
  3. 4.2.1 Global Bifidobacterium Animalis Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global Bifidobacterium Animalis Revenue by Region (2021-2026)
  5. 4.2.3 Global Bifidobacterium Animalis Revenue by Region (2027-2032)
  6. 4.2.4 Global Bifidobacterium Animalis Revenue Market Share by Region (2021-2032)
  7. 4.3 Global Bifidobacterium Animalis Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global Bifidobacterium Animalis Sales by Region
  9. 4.4.1 Global Bifidobacterium Animalis Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global Bifidobacterium Animalis Sales by Region (2021-2026)
  11. 4.4.3 Global Bifidobacterium Animalis Sales by Region (2027-2032)
  12. 4.4.4 Global Bifidobacterium Animalis Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global Bifidobacterium Animalis Revenue by Manufacturers
  2. 5.1.1 Global Bifidobacterium Animalis Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global Bifidobacterium Animalis Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global Bifidobacterium Animalis Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global Bifidobacterium Animalis Sales by Manufacturers
  6. 5.2.1 Global Bifidobacterium Animalis Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global Bifidobacterium Animalis Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global Bifidobacterium Animalis Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global Bifidobacterium Animalis Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global Bifidobacterium Animalis Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global Bifidobacterium Animalis Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global Bifidobacterium Animalis Manufacturers, Product Type & Application
  13. 5.7 Global Bifidobacterium Animalis Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global Bifidobacterium Animalis Market CR5 and HHI
  16. 5.8.2 2025 Bifidobacterium Animalis Tier 1, Tier 2, and Tier 3
6 Bifidobacterium Animalis Market by Type
  1. 6.1 Global Bifidobacterium Animalis Revenue by Type
  2. 6.1.1 Global Bifidobacterium Animalis Revenue by Type (2021-2032) & (US$ Million)
  3. 6.1.2 Global Bifidobacterium Animalis Revenue Market Share by Type (2021-2032)
  4. 6.2 Global Bifidobacterium Animalis Sales by Type
  5. 6.2.1 Global Bifidobacterium Animalis Sales by Type (2021-2032) & (t)
  6. 6.2.2 Global Bifidobacterium Animalis Sales Market Share by Type (2021-2032)
  7. 6.3 Global Bifidobacterium Animalis Price by Type
7 Bifidobacterium Animalis Market by Application
  1. 7.1 Global Bifidobacterium Animalis Revenue by Application
  2. 7.1.1 Global Bifidobacterium Animalis Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global Bifidobacterium Animalis Revenue Market Share by Application (2021-2032)
  4. 7.2 Global Bifidobacterium Animalis Sales by Application
  5. 7.2.1 Global Bifidobacterium Animalis Sales by Application (2021-2032) & (t)
  6. 7.2.2 Global Bifidobacterium Animalis Sales Market Share by Application (2021-2032)
  7. 7.3 Global Bifidobacterium Animalis Price by Application
8 Company Profiles
  1. 8.1 ADM
  2. 8.1.1 ADM Company Information
  3. 8.1.2 ADM Business Overview
  4. 8.1.3 ADM Bifidobacterium Animalis Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 ADM Bifidobacterium Animalis Product Portfolio
  6. 8.1.5 ADM Recent Developments
  7. 8.2 ATCC
  8. 8.2.1 ATCC Company Information
  9. 8.2.2 ATCC Business Overview
  10. 8.2.3 ATCC Bifidobacterium Animalis Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 ATCC Bifidobacterium Animalis Product Portfolio
  12. 8.2.5 ATCC Recent Developments
  13. 8.3 Chr. Hansen
  14. 8.3.1 Chr. Hansen Company Information
  15. 8.3.2 Chr. Hansen Business Overview
  16. 8.3.3 Chr. Hansen Bifidobacterium Animalis Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 8.3.4 Chr. Hansen Bifidobacterium Animalis Product Portfolio
  18. 8.3.5 Chr. Hansen Recent Developments
  19. 8.4 Creative Biolabs
  20. 8.4.1 Creative Biolabs Company Information
  21. 8.4.2 Creative Biolabs Business Overview
  22. 8.4.3 Creative Biolabs Bifidobacterium Animalis Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 8.4.4 Creative Biolabs Bifidobacterium Animalis Product Portfolio
  24. 8.4.5 Creative Biolabs Recent Developments
  25. 8.5 DuPont Nutrition & Biosciences
  26. 8.5.1 DuPont Nutrition & Biosciences Company Information
  27. 8.5.2 DuPont Nutrition & Biosciences Business Overview
  28. 8.5.3 DuPont Nutrition & Biosciences Bifidobacterium Animalis Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 8.5.4 DuPont Nutrition & Biosciences Bifidobacterium Animalis Product Portfolio
  30. 8.5.5 DuPont Nutrition & Biosciences Recent Developments
  31. 8.6 Fengchen Group
  32. 8.6.1 Fengchen Group Company Information
  33. 8.6.2 Fengchen Group Business Overview
  34. 8.6.3 Fengchen Group Bifidobacterium Animalis Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 8.6.4 Fengchen Group Bifidobacterium Animalis Product Portfolio
  36. 8.6.5 Fengchen Group Recent Developments
  37. 8.7 Microbiologics
  38. 8.7.1 Microbiologics Company Information
  39. 8.7.2 Microbiologics Business Overview
  40. 8.7.3 Microbiologics Bifidobacterium Animalis Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 8.7.4 Microbiologics Bifidobacterium Animalis Product Portfolio
  42. 8.7.5 Microbiologics Recent Developments
  43. 8.8 Morinaga
  44. 8.8.1 Morinaga Company Information
  45. 8.8.2 Morinaga Business Overview
  46. 8.8.3 Morinaga Bifidobacterium Animalis Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 8.8.4 Morinaga Bifidobacterium Animalis Product Portfolio
  48. 8.8.5 Morinaga Recent Developments
  49. 8.9 SynBalance
  50. 8.9.1 SynBalance Company Information
  51. 8.9.2 SynBalance Business Overview
  52. 8.9.3 SynBalance Bifidobacterium Animalis Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 8.9.4 SynBalance Bifidobacterium Animalis Product Portfolio
  54. 8.9.5 SynBalance Recent Developments
  55. 8.10 BGI Nutri
  56. 8.10.1 BGI Nutri Company Information
  57. 8.10.2 BGI Nutri Business Overview
  58. 8.10.3 BGI Nutri Bifidobacterium Animalis Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 8.10.4 BGI Nutri Bifidobacterium Animalis Product Portfolio
  60. 8.10.5 BGI Nutri Recent Developments
  61. 8.11 Wecare Probiotics
  62. 8.11.1 Wecare Probiotics Company Information
  63. 8.11.2 Wecare Probiotics Business Overview
  64. 8.11.3 Wecare Probiotics Bifidobacterium Animalis Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 8.11.4 Wecare Probiotics Bifidobacterium Animalis Product Portfolio
  66. 8.11.5 Wecare Probiotics Recent Developments
  67. 8.12 Yili Group
  68. 8.12.1 Yili Group Company Information
  69. 8.12.2 Yili Group Business Overview
  70. 8.12.3 Yili Group Bifidobacterium Animalis Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 8.12.4 Yili Group Bifidobacterium Animalis Product Portfolio
  72. 8.12.5 Yili Group Recent Developments
  73. 8.13 Wisbiom (Beijing) Biotechnology
  74. 8.13.1 Wisbiom (Beijing) Biotechnology Company Information
  75. 8.13.2 Wisbiom (Beijing) Biotechnology Business Overview
  76. 8.13.3 Wisbiom (Beijing) Biotechnology Bifidobacterium Animalis Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 8.13.4 Wisbiom (Beijing) Biotechnology Bifidobacterium Animalis Product Portfolio
  78. 8.13.5 Wisbiom (Beijing) Biotechnology Recent Developments
9 North America
  1. 9.1 North America Bifidobacterium Animalis Market Size by Type
  2. 9.1.1 North America Bifidobacterium Animalis Revenue by Type (2021-2032)
  3. 9.1.2 North America Bifidobacterium Animalis Sales by Type (2021-2032)
  4. 9.1.3 North America Bifidobacterium Animalis Price by Type (2021-2032)
  5. 9.2 North America Bifidobacterium Animalis Market Size by Application
  6. 9.2.1 North America Bifidobacterium Animalis Revenue by Application (2021-2032)
  7. 9.2.2 North America Bifidobacterium Animalis Sales by Application (2021-2032)
  8. 9.2.3 North America Bifidobacterium Animalis Price by Application (2021-2032)
  9. 9.3 North America Bifidobacterium Animalis Market Size by Country
  10. 9.3.1 North America Bifidobacterium Animalis Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America Bifidobacterium Animalis Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America Bifidobacterium Animalis Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
  15. 9.3.6 Mexico
10 Europe
  1. 10.1 Europe Bifidobacterium Animalis Market Size by Type
  2. 10.1.1 Europe Bifidobacterium Animalis Revenue by Type (2021-2032)
  3. 10.1.2 Europe Bifidobacterium Animalis Sales by Type (2021-2032)
  4. 10.1.3 Europe Bifidobacterium Animalis Price by Type (2021-2032)
  5. 10.2 Europe Bifidobacterium Animalis Market Size by Application
  6. 10.2.1 Europe Bifidobacterium Animalis Revenue by Application (2021-2032)
  7. 10.2.2 Europe Bifidobacterium Animalis Sales by Application (2021-2032)
  8. 10.2.3 Europe Bifidobacterium Animalis Price by Application (2021-2032)
  9. 10.3 Europe Bifidobacterium Animalis Market Size by Country
  10. 10.3.1 Europe Bifidobacterium Animalis Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe Bifidobacterium Animalis Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe Bifidobacterium Animalis Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Russia
  18. 10.3.9 Spain
  19. 10.3.10 Netherlands
  20. 10.3.11 Switzerland
  21. 10.3.12 Sweden
11 China
  1. 11.1 China Bifidobacterium Animalis Market Size by Type
  2. 11.1.1 China Bifidobacterium Animalis Revenue by Type (2021-2032)
  3. 11.1.2 China Bifidobacterium Animalis Sales by Type (2021-2032)
  4. 11.1.3 China Bifidobacterium Animalis Price by Type (2021-2032)
  5. 11.2 China Bifidobacterium Animalis Market Size by Application
  6. 11.2.1 China Bifidobacterium Animalis Revenue by Application (2021-2032)
  7. 11.2.2 China Bifidobacterium Animalis Sales by Application (2021-2032)
  8. 11.2.3 China Bifidobacterium Animalis Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia Bifidobacterium Animalis Market Size by Type
  2. 12.1.1 Asia Bifidobacterium Animalis Revenue by Type (2021-2032)
  3. 12.1.2 Asia Bifidobacterium Animalis Sales by Type (2021-2032)
  4. 12.1.3 Asia Bifidobacterium Animalis Price by Type (2021-2032)
  5. 12.2 Asia Bifidobacterium Animalis Market Size by Application
  6. 12.2.1 Asia Bifidobacterium Animalis Revenue by Application (2021-2032)
  7. 12.2.2 Asia Bifidobacterium Animalis Sales by Application (2021-2032)
  8. 12.2.3 Asia Bifidobacterium Animalis Price by Application (2021-2032)
  9. 12.3 Asia Bifidobacterium Animalis Market Size by Country
  10. 12.3.1 Asia Bifidobacterium Animalis Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia Bifidobacterium Animalis Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia Bifidobacterium Animalis Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA Bifidobacterium Animalis Market Size by Type
  2. 13.1.1 SAMEA Bifidobacterium Animalis Revenue by Type (2021-2032)
  3. 13.1.2 SAMEA Bifidobacterium Animalis Sales by Type (2021-2032)
  4. 13.1.3 SAMEA Bifidobacterium Animalis Price by Type (2021-2032)
  5. 13.2 SAMEA Bifidobacterium Animalis Market Size by Application
  6. 13.2.1 SAMEA Bifidobacterium Animalis Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA Bifidobacterium Animalis Sales by Application (2021-2032)
  8. 13.2.3 SAMEA Bifidobacterium Animalis Price by Application (2021-2032)
  9. 13.3 SAMEA Bifidobacterium Animalis Market Size by Country
  10. 13.3.1 SAMEA Bifidobacterium Animalis Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA Bifidobacterium Animalis Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA Bifidobacterium Animalis Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 Bifidobacterium Animalis Value Chain Analysis
  2. 14.1.1 Bifidobacterium Animalis Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 Bifidobacterium Animalis Production Mode & Process
  6. 14.2 Bifidobacterium Animalis Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 Bifidobacterium Animalis Distributors
  9. 14.2.3 Bifidobacterium Animalis Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst